Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab:
a multicenter retrospective study
京都大学 中村直和 Ann Hematol.2024 Mar 16.doi:10.1007/s00277-024-05705-z.Online ahead of print.
![](https://myeloma.jp/wp-content/themes/cocoon-master/screenshot.jpg)
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab:
a multicenter retrospective study